Big buy

Adam Morgan: large open-market buy of HRTX

$2.6M open-market purchase by Adam Morgan, Director at Heron Therapeutics,inc. /DE/, filed August 12, 2025. Learn more

Feed status Last SEC check:Loading Last Filing: Loading
View HRTX
Access Free feed
Quick read What does this view show?

What this is

Single filing record

This page shows the rows from one Form 4 filing as reported to the SEC.

Why it matters

Read the SEC filing

The original SEC document is the source record. Always verify before drawing conclusions.

How to read it

Role, size, timing

Insider activity carries more weight from senior officers, large dollar values, and clustered timing.

Big BuyHRTX
$0.42+7.69% today

Adam Morgan · Director at Heron Therapeutics,inc. /DE/

$2.6M

Adam Morgan bought $2.6M of HRTX (Heron Therapeutics,inc. /DE/).

Filed August 12, 2025

Filings

Recent insider trades

Status Loading

Loading public insider data...

Latest visible filing loading.

Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?

TickerType & RoleValue

View all HRTX insider activity →

Share

Share this story

Adam Morgan bought $2.6M of HRTX. Large open-market insider purchase reported on SEC Form 4.

Weekly recap

Get the easier version in your inbox.

Start with the free weekly recap. Upgrade later if you want the paid daily brief.

Free weekly recap. No login required. Unsubscribe any time.

Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →